Anti-Clogging Effect of Continuous Hemodiafiltration With Blood Recirculation.


Journal

ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109

Informations de publication

Date de publication:
01 Dec 2023
Historique:
medline: 4 12 2023
pubmed: 11 11 2023
entrez: 10 11 2023
Statut: ppublish

Résumé

Pediatric dialysis requires low flow from the body, but greater flow is needed to prevent clogging. As a solution, we developed a new continuous hemodiafiltration system with blood recirculation (CHDF-R), which enables separate settings for blood flow from the body and to the hemofilter. We compared CHDF-R with conventional continuous hemodiafiltration (CHDF) of bovine plasma and blood by monitoring the transmembrane pressure (TMP) and observing the hemofilter membrane surface. When using bovine plasma, the postdialysis TMP with CHDF-R was significantly lower than with CHDF (median CHDF, 23.7; median CHDF-R, 18.1; p = 0.029). Likewise, when using bovine blood, the postdialysis TMP was also significantly lower with CHDF-R than with CHDF (median CHDF, 150; median CHDF-R, 100; p = 0.029). Moreover, the area of clogged membrane was significantly smaller with CHDF-R than with CHDF, and the inner membrane surface showed less material deposition with CHDF-R than CHDF. CHDF-R thus appears to suppress accumulation of clogging substances by producing higher shear stress within hollow fiber membranes.

Identifiants

pubmed: 37949050
doi: 10.1097/MAT.0000000000002053
pii: 00002480-990000000-00353
doi:

Substances chimiques

Membranes, Artificial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1106-1111

Informations de copyright

Copyright © ASAIO 2023.

Déclaration de conflit d'intérêts

Disclosure: The authors have no conflicts of interest to report.

Références

Khwaja A: KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 120: c179–c184, 2012.
Ferguson LM, Dreisbach AW, Csongrádi E, Juncos LA, Fulop T: Recurring extracorporeal circuit clotting during continuous renal replacement therapy in fungal sepsis: successful treatment with argatroban. Am J Med Sci. 345: 256–258, 2013.
Wen Y, LeDoux JR, Mohamed M, et al.: Dialysis filter life, anticoagulation, and inflammation in COVID-19 and acute kidney injury. Kidney360. 1: 1426–1431, 2020.
Levi M, van der Poll T: Coagulation and sepsis. Thromb Res. 149: 38–44, 2017.
Tandukar S, Palevsky PM: Continuous renal replacement therapy: Who, when, why, and How. Chest. 155: 626–638, 2019.
Canaud B, Vienken J, Ash S, Ward RA; Kidney Health Initiative HDF Workgroup: Hemodiafiltration to address unmet medical needs ESKD patients. Clin J Am Soc Nephrol. 13: 1435–1443, 2018.
Fraser KH, Zhang T, Taskin ME, Griffith BP, Wu ZJ: Computational fluid dynamics analysis of thrombosis potential in left ventricular assist device drainage cannulae. ASAIO J. 56: 157–163, 2010.
de Galasso L, Picca S, Guzzo I: Dialysis modalities for the management of pediatric acute kidney injury. Pediatr Nephrol. 35: 753–765, 2020.
Dukhin SS, Tabani Y, Lai R, Labib OA, Zydney AL, Labib ME: Outside-in hemofiltration for prolonged operation without clogging. J Memb Sci. 464: 173–178, 2014.
Mohamad EH: Accelerated hemodialysis: A new safe and simple method of a high filter-low patient blood flow rate hemodialysis. Ren Fail. 21: 515–523, 1999.
Brendolan A, Ronco C, Crepaldi C, et al.: Double pass dialysis: A new method of renal replacement in patients with malfunctioning vascular access. Int J Artif Organs. 17: 379–384, 1994.
Ikeda Y, Kishi T, Kishi C, et al.: Partial blood recirculation: A new trial for prolonging filter life during continuous hemodiafiltration. Ther Apher Dial. 12: 96–99, 2008.
Honore PM, Spapen HD: What a clinician should know about a renal replacement membrane? J Transl Int Med. 6: 62–65, 2018.
Vinsonneau C, Allain-Launay E, Blayau C, et al.: Renal replacement therapy in adult and pediatric intensive care: Recommendations by an expert panel from the French Intensive Care Society (SRLF) with the French Society of Anesthesia Intensive Care (SFAR) French Group for Pediatric Intensive Care Emergencies (GFRUP) the French Dialysis Society (SFD). Ann Intensive Care. 5: 58, 2015.
Frank RD, Weber J, Dresbach H, Thelen H, Weiss C, Floege J: Role of contact system activation in hemodialyzer-induced thrombogenicity. Kidney Int. 60: 1972–1981, 2001.
Daugirdas JT: Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol. 4: 1205–1213, 1993.
Ronco C, Brendolan A, Lupi A, Metry G, Levin NW: Effects of a reduced inner diameter of hollow fibers in hemodialyzers. Kidney Int. 58: 809–817, 2000.
Westerhof N, Stergiopulos N, Noble MIM, Westerhof BE: Snapshots of Hemodynamics: An Aid for Clinical Research and Graduate Education. Cham, Switzerland, Springer International Publishing AG, 2019.
Liao Z, Klein E, Poh C, et al.: Measurement of hollow fiber membrane transport properties in hemodialyzers. J Membr Sci, 256: 176–183, 2005.
Field RW, Wu JJ: Permeate flux in ultrafiltration processes-understandings and misunderstandings. Membranes (Basel). 12: 187, 2022.

Auteurs

Kazuhisa Nishimori (K)

From the Department of Nephrology, Faculty of Medical Sciences, University of Fukui.

Kenji Kasuno (K)

From the Department of Nephrology, Faculty of Medical Sciences, University of Fukui.

Naoki Takahashi (N)

From the Department of Nephrology, Faculty of Medical Sciences, University of Fukui.

Fumihiro Nishimura (F)

Headquarters for Innovative Society-Academia Cooperation, University of Fukui, Fukui, Japan.

Yuki Shimamoto (Y)

From the Department of Nephrology, Faculty of Medical Sciences, University of Fukui.

Hideki Kimura (H)

From the Department of Nephrology, Faculty of Medical Sciences, University of Fukui.

Masayuki Iwano (M)

From the Department of Nephrology, Faculty of Medical Sciences, University of Fukui.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH